BIOMAT Database Logo BIOMAT Database Logo

[Erythromycin therapy of nasopharyngeal carriers of pathogenic staphylococci]. 1957

M FORTE, and S CANAZZA

UI MeSH Term Description Entries
D008837 Micrococcus A genus of gram-positive, spherical bacteria found in soils and fresh water, and frequently on the skin of man and other animals.
D009305 Nasopharynx The top portion of the pharynx situated posterior to the nose and superior to the SOFT PALATE. The nasopharynx is the posterior extension of the nasal cavities and has a respiratory function. Rhinopharynx,Choanae,Nasopharynges,Nasopharynxes,Rhinopharynges,Rhinopharynxes
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.

Related Publications

M FORTE, and S CANAZZA
[Erythromycin and ecomonovocillin therapy of carriers of pathogenic staphylococci].
August 1965, Antibiotiki,
M FORTE, and S CANAZZA
[Bacitracin in the treatment of nasopharyngeal carriers of pathogenic Staphylococci].
January 1956, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
M FORTE, and S CANAZZA
[Carriers of pathogenic staphylococci in an obstetric clinic].
February 1966, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M FORTE, and S CANAZZA
[Combination erythromycin-oleandomycin: favorable bactericidal effect on pathogenic staphylococci].
January 1959, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
M FORTE, and S CANAZZA
[Treatment of carriers of pathogenic staphylococci in maternity homes].
September 1969, Fel'dsher i akusherka,
M FORTE, and S CANAZZA
[Treatment of carriers of pathogenic staphylococci with neomycin ointment].
March 1967, Antibiotiki,
M FORTE, and S CANAZZA
[Erythromycin in therapy of diphtheria carriers].
July 1958, La Clinica terapeutica,
M FORTE, and S CANAZZA
[Carriers of pathogenic & antibiotic-resistant staphylococci in hospital ward infections].
March 1958, Pediatria polska,
M FORTE, and S CANAZZA
[Phage typing of pathogenic staphylococci isolated from patients and carriers].
February 1974, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M FORTE, and S CANAZZA
[Some biological and epidemiological characteristics of staphylococci isolated from nasopharyngeal carriers].
January 1971, Microbiologia, parazitologia, epidemiologia,
Copied contents to your clipboard!